Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Cebranopadol Efficacy and Safety in Diabetic Patients Suffering From Chronic Pain Caused by Damage to the Nerves
Efficacy, Safety and Tolerability of Multiple Doses of Oral Cebranopadol in Subjects With Moderate to Severe Chronic Pain Due to Diabetic Peripheral Neuropathy.
Status: Enrolling
Updated:  10/1/2014
US021
mi
from
New York, NY
Cebranopadol Efficacy and Safety in Diabetic Patients Suffering From Chronic Pain Caused by Damage to the Nerves
Efficacy, Safety and Tolerability of Multiple Doses of Oral Cebranopadol in Subjects With Moderate to Severe Chronic Pain Due to Diabetic Peripheral Neuropathy.
Status: Enrolling
Updated: 10/1/2014
US021
mi
from
New York, NY
Click here to add this to my saved trials
Assess Safety, Bio-distribution, Dosimetry, and Optimize Imaging Protocol of GEH120714 (18F) Injection, in Healthy Volunteers and Participants With Relapsing and Remitting Multiple Sclerosis (rrMS)
A Phase 1, Open-label, Non-randomized Study to Assess Safety, Bio-distribution, and Radiation Dosimetry, and Optimize the Imaging Protocol of GEH120714 (18F) Injection, a Marker of Microglial Activation, in Healthy Volunteers and Participants With Relapsing and Remitting Multiple Sclerosis (rrMS)
Status: Enrolling
Updated:  10/7/2014
GE Healthcare
mi
from
Princeton, NJ
Assess Safety, Bio-distribution, Dosimetry, and Optimize Imaging Protocol of GEH120714 (18F) Injection, in Healthy Volunteers and Participants With Relapsing and Remitting Multiple Sclerosis (rrMS)
A Phase 1, Open-label, Non-randomized Study to Assess Safety, Bio-distribution, and Radiation Dosimetry, and Optimize the Imaging Protocol of GEH120714 (18F) Injection, a Marker of Microglial Activation, in Healthy Volunteers and Participants With Relapsing and Remitting Multiple Sclerosis (rrMS)
Status: Enrolling
Updated: 10/7/2014
GE Healthcare
mi
from
Princeton, NJ
Click here to add this to my saved trials
Consolidation & Interference in Multiple Sclerosis
Consolidation & Interference in Multiple Sclerosis
Status: Enrolling
Updated:  10/7/2014
Kessler Foundation
mi
from
West Orange, NJ
Consolidation & Interference in Multiple Sclerosis
Consolidation & Interference in Multiple Sclerosis
Status: Enrolling
Updated: 10/7/2014
Kessler Foundation
mi
from
West Orange, NJ
Click here to add this to my saved trials
Crossover Comparison of MultiHance and Dotarem
Phase IV, Double Blind, Multi-Center, Randomized, Two-Arm Crossover Study to Compare 0.1 mmol/kg of MultiHance With 0.1 mmol/kg of Dotarem and 0.05 mmol/kg of MultiHance With 0.1 mmol/kg of Dotarem in Magnetic Resonance Imaging (MRI) of the Brain
Status: Enrolling
Updated:  10/9/2014
Samaritan Health Services
mi
from
Corvallis, OR
Crossover Comparison of MultiHance and Dotarem
Phase IV, Double Blind, Multi-Center, Randomized, Two-Arm Crossover Study to Compare 0.1 mmol/kg of MultiHance With 0.1 mmol/kg of Dotarem and 0.05 mmol/kg of MultiHance With 0.1 mmol/kg of Dotarem in Magnetic Resonance Imaging (MRI) of the Brain
Status: Enrolling
Updated: 10/9/2014
Samaritan Health Services
mi
from
Corvallis, OR
Click here to add this to my saved trials
Open Label Clinical Trial of Vitamin D in Children With Autism
Open Label Clinical Trial of Vitamin D Dosage Tolerability, and Effect on Behavioral Measures in Children With Autism
Status: Enrolling
Updated:  10/20/2014
University of California at San Francisco
mi
from
San Francisco, CA
Open Label Clinical Trial of Vitamin D in Children With Autism
Open Label Clinical Trial of Vitamin D Dosage Tolerability, and Effect on Behavioral Measures in Children With Autism
Status: Enrolling
Updated: 10/20/2014
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
SENSE Theatre Intervention for Children With Autism Spectrum Disorder (ASD)
SENSE Theatre Research Program
Status: Enrolling
Updated:  10/27/2014
Vanderbilt Kennedy Center
mi
from
Nashville, TN
SENSE Theatre Intervention for Children With Autism Spectrum Disorder (ASD)
SENSE Theatre Research Program
Status: Enrolling
Updated: 10/27/2014
Vanderbilt Kennedy Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetic Profiles of BIIB017 (Peginterferon Beta-1a) and Rebif® (Interferon Beta-1a) in Healthy Volunteers
An Open-label Crossover Phase 1 Study to Evaluate the Pharmacokinetic Profiles of BIIB017 (Peginterferon Beta-1a) and Rebif® (Interferon Beta-1a) in Healthy Volunteers
Status: Enrolling
Updated:  11/6/2014
Clinical Research Facility
mi
from
Evansville, IN
Study to Evaluate the Pharmacokinetic Profiles of BIIB017 (Peginterferon Beta-1a) and Rebif® (Interferon Beta-1a) in Healthy Volunteers
An Open-label Crossover Phase 1 Study to Evaluate the Pharmacokinetic Profiles of BIIB017 (Peginterferon Beta-1a) and Rebif® (Interferon Beta-1a) in Healthy Volunteers
Status: Enrolling
Updated: 11/6/2014
Clinical Research Facility
mi
from
Evansville, IN
Click here to add this to my saved trials
Randomized Controlled Trial of Argatroban With Tissue Plasminogen Activator (tPA) for Acute Stroke
ARTSS-2: A Pilot, Phase 2b, Randomized, Multi-center Trial of Argatroban in Combination With Recombinant Tissue Plasminogen Activator for Acute Stroke
Status: Enrolling
Updated:  11/10/2014
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Randomized Controlled Trial of Argatroban With Tissue Plasminogen Activator (tPA) for Acute Stroke
ARTSS-2: A Pilot, Phase 2b, Randomized, Multi-center Trial of Argatroban in Combination With Recombinant Tissue Plasminogen Activator for Acute Stroke
Status: Enrolling
Updated: 11/10/2014
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Grass Observational Study
An Observational Multi-Centre Field Study to Assess Symptom Scores and Allergy Medication Usage in Subjects With a History of Grass-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  11/13/2014
Clinical Research Facility
mi
from
Washington,
Grass Observational Study
An Observational Multi-Centre Field Study to Assess Symptom Scores and Allergy Medication Usage in Subjects With a History of Grass-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 11/13/2014
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
Grass Observational Study
An Observational Multi-Centre Field Study to Assess Symptom Scores and Allergy Medication Usage in Subjects With a History of Grass-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  11/13/2014
Clinical Research Facility
mi
from
Normal, IL
Grass Observational Study
An Observational Multi-Centre Field Study to Assess Symptom Scores and Allergy Medication Usage in Subjects With a History of Grass-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 11/13/2014
Clinical Research Facility
mi
from
Normal, IL
Click here to add this to my saved trials
Grass Observational Study
An Observational Multi-Centre Field Study to Assess Symptom Scores and Allergy Medication Usage in Subjects With a History of Grass-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  11/13/2014
Clinical Research Facility
mi
from
Sylvania, OH
Grass Observational Study
An Observational Multi-Centre Field Study to Assess Symptom Scores and Allergy Medication Usage in Subjects With a History of Grass-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 11/13/2014
Clinical Research Facility
mi
from
Sylvania, OH
Click here to add this to my saved trials
Grass Observational Study
An Observational Multi-Centre Field Study to Assess Symptom Scores and Allergy Medication Usage in Subjects With a History of Grass-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  11/13/2014
Clinical Research Facility
mi
from
Medford, OR
Grass Observational Study
An Observational Multi-Centre Field Study to Assess Symptom Scores and Allergy Medication Usage in Subjects With a History of Grass-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 11/13/2014
Clinical Research Facility
mi
from
Medford, OR
Click here to add this to my saved trials
Grass Observational Study
An Observational Multi-Centre Field Study to Assess Symptom Scores and Allergy Medication Usage in Subjects With a History of Grass-Induced Rhinoconjunctivitis
Status: Enrolling
Updated:  11/13/2014
Clinical Research Facility
mi
from
Spokane, WA
Grass Observational Study
An Observational Multi-Centre Field Study to Assess Symptom Scores and Allergy Medication Usage in Subjects With a History of Grass-Induced Rhinoconjunctivitis
Status: Enrolling
Updated: 11/13/2014
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Milnacipran in Autism and the Functional Locus Coeruleus and Noradrenergic Model of Autism
Milnacipran in Autism and the Functional Locus Coeruleus and Noradrenergic Model of Autism
Status: Enrolling
Updated:  11/19/2014
Montefiore Medical Center, Albert Einstein College of Medicine
mi
from
Bronx, NY
Milnacipran in Autism and the Functional Locus Coeruleus and Noradrenergic Model of Autism
Milnacipran in Autism and the Functional Locus Coeruleus and Noradrenergic Model of Autism
Status: Enrolling
Updated: 11/19/2014
Montefiore Medical Center, Albert Einstein College of Medicine
mi
from
Bronx, NY
Click here to add this to my saved trials
Physical Activity in Multiple Sclerosis (MS): A Novel Approach to Study Outcomes
Physical Activity in Multiple Sclerosis (MS): A Novel Approach to Study Outcomes
Status: Enrolling
Updated:  11/20/2014
Kessler Foundation
mi
from
West Orange, NJ
Physical Activity in Multiple Sclerosis (MS): A Novel Approach to Study Outcomes
Physical Activity in Multiple Sclerosis (MS): A Novel Approach to Study Outcomes
Status: Enrolling
Updated: 11/20/2014
Kessler Foundation
mi
from
West Orange, NJ
Click here to add this to my saved trials
Treating New Learning and Memory Deficits in Progressive Multiple Sclerosis (MS)
Treating New Learning and Memory Deficits in Progressive Multiple Sclerosis (MS)
Status: Enrolling
Updated:  11/21/2014
Kessler Foundation
mi
from
West Orange, NJ
Treating New Learning and Memory Deficits in Progressive Multiple Sclerosis (MS)
Treating New Learning and Memory Deficits in Progressive Multiple Sclerosis (MS)
Status: Enrolling
Updated: 11/21/2014
Kessler Foundation
mi
from
West Orange, NJ
Click here to add this to my saved trials
Window to Hope-Evaluating a Psychological Treatment for Hopelessness Among Veterans With Traumatic Brain Injury
Window to Hope-Evaluating a Psychological Treatment for Hopelessness Among Veterans With Traumatic Brain Injury
Status: Enrolling
Updated:  11/24/2014
VA Eastern Colorado Health Care System
mi
from
Denver, CO
Window to Hope-Evaluating a Psychological Treatment for Hopelessness Among Veterans With Traumatic Brain Injury
Window to Hope-Evaluating a Psychological Treatment for Hopelessness Among Veterans With Traumatic Brain Injury
Status: Enrolling
Updated: 11/24/2014
VA Eastern Colorado Health Care System
mi
from
Denver, CO
Click here to add this to my saved trials
Trial Comparing Different Stimulation Paradigms in Patients Treated With Vagus Nerve Stimulation for Refractory Epilepsy
Prospective Randomized Trial Comparing Different Stimulation Paradigms in Patients Treated With Vagus Nerve Stimulation for Refractory Epilepsy
Status: Enrolling
Updated:  12/4/2014
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Trial Comparing Different Stimulation Paradigms in Patients Treated With Vagus Nerve Stimulation for Refractory Epilepsy
Prospective Randomized Trial Comparing Different Stimulation Paradigms in Patients Treated With Vagus Nerve Stimulation for Refractory Epilepsy
Status: Enrolling
Updated: 12/4/2014
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Intraventricular Hemorrhage and Post Hemorrhagic Ventricular Dilation: Natural Course, Treatment, and Outcome
Intraventricular Hemorrhage and Post Hemorrhagic Ventricular Dilation: Natural Course, Treatment, and Outcome
Status: Enrolling
Updated:  12/4/2014
University of Utah
mi
from
Salt Lake City, UT
Intraventricular Hemorrhage and Post Hemorrhagic Ventricular Dilation: Natural Course, Treatment, and Outcome
Intraventricular Hemorrhage and Post Hemorrhagic Ventricular Dilation: Natural Course, Treatment, and Outcome
Status: Enrolling
Updated: 12/4/2014
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
HydroCoil Cerebral Aneurysm Treatment Trial
HydroCoil Cerebral Aneurysm Treatment Trial
Status: Enrolling
Updated:  12/11/2014
Mercy Stroke Center
mi
from
Carmichael, CA
HydroCoil Cerebral Aneurysm Treatment Trial
HydroCoil Cerebral Aneurysm Treatment Trial
Status: Enrolling
Updated: 12/11/2014
Mercy Stroke Center
mi
from
Carmichael, CA
Click here to add this to my saved trials
HydroCoil Cerebral Aneurysm Treatment Trial
HydroCoil Cerebral Aneurysm Treatment Trial
Status: Enrolling
Updated:  12/11/2014
St Luke's - Roosevelt Hospital Center
mi
from
New York, NY
HydroCoil Cerebral Aneurysm Treatment Trial
HydroCoil Cerebral Aneurysm Treatment Trial
Status: Enrolling
Updated: 12/11/2014
St Luke's - Roosevelt Hospital Center
mi
from
New York, NY
Click here to add this to my saved trials
HydroCoil Cerebral Aneurysm Treatment Trial
HydroCoil Cerebral Aneurysm Treatment Trial
Status: Enrolling
Updated:  12/11/2014
Oregon Health and Science University
mi
from
Portland, OR
HydroCoil Cerebral Aneurysm Treatment Trial
HydroCoil Cerebral Aneurysm Treatment Trial
Status: Enrolling
Updated: 12/11/2014
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
HydroCoil Cerebral Aneurysm Treatment Trial
HydroCoil Cerebral Aneurysm Treatment Trial
Status: Enrolling
Updated:  12/11/2014
Medical college of South Carolina
mi
from
Charleston, SC
HydroCoil Cerebral Aneurysm Treatment Trial
HydroCoil Cerebral Aneurysm Treatment Trial
Status: Enrolling
Updated: 12/11/2014
Medical college of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
HydroCoil Cerebral Aneurysm Treatment Trial
HydroCoil Cerebral Aneurysm Treatment Trial
Status: Enrolling
Updated:  12/11/2014
University of Virginia
mi
from
Charlottesville, VA
HydroCoil Cerebral Aneurysm Treatment Trial
HydroCoil Cerebral Aneurysm Treatment Trial
Status: Enrolling
Updated: 12/11/2014
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
HydroCoil Cerebral Aneurysm Treatment Trial
HydroCoil Cerebral Aneurysm Treatment Trial
Status: Enrolling
Updated:  12/11/2014
Sentara Norfolk General Hospital
mi
from
Norfolk, VA
HydroCoil Cerebral Aneurysm Treatment Trial
HydroCoil Cerebral Aneurysm Treatment Trial
Status: Enrolling
Updated: 12/11/2014
Sentara Norfolk General Hospital
mi
from
Norfolk, VA
Click here to add this to my saved trials
HydroCoil Cerebral Aneurysm Treatment Trial
HydroCoil Cerebral Aneurysm Treatment Trial
Status: Enrolling
Updated:  12/11/2014
University of Southern California
mi
from
Los Angeles, CA
HydroCoil Cerebral Aneurysm Treatment Trial
HydroCoil Cerebral Aneurysm Treatment Trial
Status: Enrolling
Updated: 12/11/2014
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
HydroCoil Cerebral Aneurysm Treatment Trial
HydroCoil Cerebral Aneurysm Treatment Trial
Status: Enrolling
Updated:  12/11/2014
University of Florida
mi
from
Gainesville, FL
HydroCoil Cerebral Aneurysm Treatment Trial
HydroCoil Cerebral Aneurysm Treatment Trial
Status: Enrolling
Updated: 12/11/2014
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
HydroCoil Cerebral Aneurysm Treatment Trial
HydroCoil Cerebral Aneurysm Treatment Trial
Status: Enrolling
Updated:  12/11/2014
Saint Louis University
mi
from
St. Louis, MO
HydroCoil Cerebral Aneurysm Treatment Trial
HydroCoil Cerebral Aneurysm Treatment Trial
Status: Enrolling
Updated: 12/11/2014
Saint Louis University
mi
from
St. Louis, MO
Click here to add this to my saved trials
HydroCoil Cerebral Aneurysm Treatment Trial
HydroCoil Cerebral Aneurysm Treatment Trial
Status: Enrolling
Updated:  12/11/2014
University of Texas Southwest Medical Center
mi
from
Dallas, TX
HydroCoil Cerebral Aneurysm Treatment Trial
HydroCoil Cerebral Aneurysm Treatment Trial
Status: Enrolling
Updated: 12/11/2014
University of Texas Southwest Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
HydroCoil Cerebral Aneurysm Treatment Trial
HydroCoil Cerebral Aneurysm Treatment Trial
Status: Enrolling
Updated:  12/11/2014
The Methodist Research Institute
mi
from
Houston, TX
HydroCoil Cerebral Aneurysm Treatment Trial
HydroCoil Cerebral Aneurysm Treatment Trial
Status: Enrolling
Updated: 12/11/2014
The Methodist Research Institute
mi
from
Houston, TX
Click here to add this to my saved trials
Effects of Protein Supplementation on Lean Body Mass Recovery From Extreme Military Training
Effect of Protein Supplementation on Lean Body Mass Recovery and Physiological Resilience Following Survive, Evade, Resist, Escape (SERE) School
Status: Enrolling
Updated:  12/17/2014
US Marine SERE School
mi
from
Camp Lejeune, NC
Effects of Protein Supplementation on Lean Body Mass Recovery From Extreme Military Training
Effect of Protein Supplementation on Lean Body Mass Recovery and Physiological Resilience Following Survive, Evade, Resist, Escape (SERE) School
Status: Enrolling
Updated: 12/17/2014
US Marine SERE School
mi
from
Camp Lejeune, NC
Click here to add this to my saved trials
Real-world Outcomes on Tecfidera® (BG00012, Dimethyl Fumarate) Post-Tysabri® (BG00002, Natalizumab)
A Multicenter, Retrospective, Observational Study Evaluating Real-world Clinical Outcomes in Relapsing-remitting Multiple Sclerosis Patients Who Transition From Tysabri® (Natalizumab) to Tecfidera® (Dimethyl Fumarate)
Status: Enrolling
Updated:  12/18/2014
Clinical Research Facility
mi
from
New York, NY
Real-world Outcomes on Tecfidera® (BG00012, Dimethyl Fumarate) Post-Tysabri® (BG00002, Natalizumab)
A Multicenter, Retrospective, Observational Study Evaluating Real-world Clinical Outcomes in Relapsing-remitting Multiple Sclerosis Patients Who Transition From Tysabri® (Natalizumab) to Tecfidera® (Dimethyl Fumarate)
Status: Enrolling
Updated: 12/18/2014
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Dose Optimization for Stroke Evaluation
Optimizing the Dose of Rehabilitation After Stroke.
Status: Enrolling
Updated:  12/22/2014
University of Southern California Health Sciences Campus
mi
from
Los Angeles, CA
Dose Optimization for Stroke Evaluation
Optimizing the Dose of Rehabilitation After Stroke.
Status: Enrolling
Updated: 12/22/2014
University of Southern California Health Sciences Campus
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Dasotraline SEP360-105 Pediatric PK/PD Study
A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Evaluation of Single Oral Doses of SEP-225289 in Subjects 6 to 17 Years of Age With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated:  12/29/2014
Woodland International Research Group, Inc.
mi
from
Little Rock, AR
Dasotraline SEP360-105 Pediatric PK/PD Study
A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Evaluation of Single Oral Doses of SEP-225289 in Subjects 6 to 17 Years of Age With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated: 12/29/2014
Woodland International Research Group, Inc.
mi
from
Little Rock, AR
Click here to add this to my saved trials
Dasotraline SEP360-105 Pediatric PK/PD Study
A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Evaluation of Single Oral Doses of SEP-225289 in Subjects 6 to 17 Years of Age With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated:  12/29/2014
MCB Clinical Research Centers
mi
from
Colorado Springs, CO
Dasotraline SEP360-105 Pediatric PK/PD Study
A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Evaluation of Single Oral Doses of SEP-225289 in Subjects 6 to 17 Years of Age With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated: 12/29/2014
MCB Clinical Research Centers
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Dasotraline SEP360-105 Pediatric PK/PD Study
A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Evaluation of Single Oral Doses of SEP-225289 in Subjects 6 to 17 Years of Age With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated:  12/29/2014
Palm Springs Research Institute
mi
from
Hialeah, FL
Dasotraline SEP360-105 Pediatric PK/PD Study
A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Evaluation of Single Oral Doses of SEP-225289 in Subjects 6 to 17 Years of Age With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated: 12/29/2014
Palm Springs Research Institute
mi
from
Hialeah, FL
Click here to add this to my saved trials
Dasotraline SEP360-105 Pediatric PK/PD Study
A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Evaluation of Single Oral Doses of SEP-225289 in Subjects 6 to 17 Years of Age With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated:  12/29/2014
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Dasotraline SEP360-105 Pediatric PK/PD Study
A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Evaluation of Single Oral Doses of SEP-225289 in Subjects 6 to 17 Years of Age With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated: 12/29/2014
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Click here to add this to my saved trials
Dasotraline SEP360-105 Pediatric PK/PD Study
A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Evaluation of Single Oral Doses of SEP-225289 in Subjects 6 to 17 Years of Age With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated:  12/29/2014
iResearch Atlanta LLC
mi
from
Decatur, GA
Dasotraline SEP360-105 Pediatric PK/PD Study
A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Evaluation of Single Oral Doses of SEP-225289 in Subjects 6 to 17 Years of Age With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated: 12/29/2014
iResearch Atlanta LLC
mi
from
Decatur, GA
Click here to add this to my saved trials
Dasotraline SEP360-105 Pediatric PK/PD Study
A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Evaluation of Single Oral Doses of SEP-225289 in Subjects 6 to 17 Years of Age With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated:  12/29/2014
Louisiana Research Associates, Inc.
mi
from
New Orleans, LA
Dasotraline SEP360-105 Pediatric PK/PD Study
A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Evaluation of Single Oral Doses of SEP-225289 in Subjects 6 to 17 Years of Age With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated: 12/29/2014
Louisiana Research Associates, Inc.
mi
from
New Orleans, LA
Click here to add this to my saved trials
Dasotraline SEP360-105 Pediatric PK/PD Study
A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Evaluation of Single Oral Doses of SEP-225289 in Subjects 6 to 17 Years of Age With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated:  12/29/2014
Wake Research, LLC
mi
from
Raleigh, NC
Dasotraline SEP360-105 Pediatric PK/PD Study
A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Evaluation of Single Oral Doses of SEP-225289 in Subjects 6 to 17 Years of Age With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated: 12/29/2014
Wake Research, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
Dasotraline SEP360-105 Pediatric PK/PD Study
A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Evaluation of Single Oral Doses of SEP-225289 in Subjects 6 to 17 Years of Age With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated:  12/29/2014
Cutting Edge Research Group
mi
from
Oklahoma City, OK
Dasotraline SEP360-105 Pediatric PK/PD Study
A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Evaluation of Single Oral Doses of SEP-225289 in Subjects 6 to 17 Years of Age With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated: 12/29/2014
Cutting Edge Research Group
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Dasotraline SEP360-105 Pediatric PK/PD Study
A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Evaluation of Single Oral Doses of SEP-225289 in Subjects 6 to 17 Years of Age With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated:  12/29/2014
IPS Research Company
mi
from
Oklahoma City, OK
Dasotraline SEP360-105 Pediatric PK/PD Study
A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Evaluation of Single Oral Doses of SEP-225289 in Subjects 6 to 17 Years of Age With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated: 12/29/2014
IPS Research Company
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Dasotraline SEP360-105 Pediatric PK/PD Study
A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Evaluation of Single Oral Doses of SEP-225289 in Subjects 6 to 17 Years of Age With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated:  12/29/2014
Clinical Trials of Texas, Inc. (CTT)
mi
from
San Antonio, TX
Dasotraline SEP360-105 Pediatric PK/PD Study
A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Evaluation of Single Oral Doses of SEP-225289 in Subjects 6 to 17 Years of Age With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated: 12/29/2014
Clinical Trials of Texas, Inc. (CTT)
mi
from
San Antonio, TX
Click here to add this to my saved trials
Dasotraline SEP360-105 Pediatric PK/PD Study
A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Evaluation of Single Oral Doses of SEP-225289 in Subjects 6 to 17 Years of Age With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated:  12/29/2014
Road Runner Research
mi
from
San Antonio, TX
Dasotraline SEP360-105 Pediatric PK/PD Study
A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Evaluation of Single Oral Doses of SEP-225289 in Subjects 6 to 17 Years of Age With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated: 12/29/2014
Road Runner Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
Dasotraline SEP360-105 Pediatric PK/PD Study
A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Evaluation of Single Oral Doses of SEP-225289 in Subjects 6 to 17 Years of Age With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated:  12/29/2014
Aspen Clinical Research, LLC
mi
from
Orem, UT
Dasotraline SEP360-105 Pediatric PK/PD Study
A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Evaluation of Single Oral Doses of SEP-225289 in Subjects 6 to 17 Years of Age With Attention Deficit Hyperactivity Disorder
Status: Enrolling
Updated: 12/29/2014
Aspen Clinical Research, LLC
mi
from
Orem, UT
Click here to add this to my saved trials
Medical Device for Magnetic Therapy for Spinal Cord Injuries (SCI)
Medical Device for Magnetic Therapy for Spinal Cord Injuries (SCIMAG)
Status: Enrolling
Updated:  1/6/2015
Gaviota Clinic
mi
from
Newark, NJ
Medical Device for Magnetic Therapy for Spinal Cord Injuries (SCI)
Medical Device for Magnetic Therapy for Spinal Cord Injuries (SCIMAG)
Status: Enrolling
Updated: 1/6/2015
Gaviota Clinic
mi
from
Newark, NJ
Click here to add this to my saved trials
Physical Telerehabilitation in Veterans With Multiple Sclerosis
Physical Telerehabilitation in Veterans With Multiple Sclerosis
Status: Enrolling
Updated:  1/20/2015
University of Maryland
mi
from
Baltimore, MD
Physical Telerehabilitation in Veterans With Multiple Sclerosis
Physical Telerehabilitation in Veterans With Multiple Sclerosis
Status: Enrolling
Updated: 1/20/2015
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Evaluation Of Biomarkers Associated With Sports Induced Concussions In College Student Athletes
A Prospective Evaluation Of Biomarkers Associated With Sports Induced Concussions In College Student Athletes
Status: Enrolling
Updated:  1/26/2015
University of Florida
mi
from
Gainesville, FL
A Evaluation Of Biomarkers Associated With Sports Induced Concussions In College Student Athletes
A Prospective Evaluation Of Biomarkers Associated With Sports Induced Concussions In College Student Athletes
Status: Enrolling
Updated: 1/26/2015
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Allopregnanolone for the Treatment of Traumatic Brain Injury
A Double-blind, Placebo-controlled, Randomized Clinical Trial of Allopregnanolone for the Treatment of Traumatic Brain Injury
Status: Enrolling
Updated:  2/2/2015
University of Southern California
mi
from
Los Angeles, CA
Allopregnanolone for the Treatment of Traumatic Brain Injury
A Double-blind, Placebo-controlled, Randomized Clinical Trial of Allopregnanolone for the Treatment of Traumatic Brain Injury
Status: Enrolling
Updated: 2/2/2015
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Allopregnanolone for the Treatment of Traumatic Brain Injury
A Double-blind, Placebo-controlled, Randomized Clinical Trial of Allopregnanolone for the Treatment of Traumatic Brain Injury
Status: Enrolling
Updated:  2/2/2015
University of California, Davis Medical Center
mi
from
Sacramento, CA
Allopregnanolone for the Treatment of Traumatic Brain Injury
A Double-blind, Placebo-controlled, Randomized Clinical Trial of Allopregnanolone for the Treatment of Traumatic Brain Injury
Status: Enrolling
Updated: 2/2/2015
University of California, Davis Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials